NCT00351468 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 302
- units
- Participants
- groups
- description
- Open-label eltrombopag was supplied in 25, 50, 75 mg tablets. All subjects started at 50mg once daily and dose was increased or decreased based on platelet count (target range 50-200Gi/L). Alternate days and interruption of dosing was permitted to maintain target range of platelet count. Doses could range from 25 to 75mg. Subjects could remain on treatment up to 2 years.
- id
- BG000
- title
- Eltrombopag
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 15.61
- value
- 48.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 201
- title
- Female
- measurements
- group Id
- BG000
- value
- 101
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 101
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 201
- title
- No
- param Type
- NUMBER
- title
- Concomitant ITP Medication at Baseline
- unit Of Measure
- Participant
- classes
- categories
- measurements
- group Id
- BG000
- value
- 115
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 187
- title
- No
- param Type
- NUMBER
- title
- Splenectomy Status at Baseline
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 211
- title
- <30 Gi/L
- categories
- measurements
- group Id
- BG000
- value
- 52
- title
- 30 - 50 Gi/L
- categories
- measurements
- group Id
- BG000
- value
- 39
- title
- > 50 Gi/L
- param Type
- NUMBER
- title
- Baseline Platelet Count
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 302
- units
- Participants
- groups
- description
- Open-label eltrombopag was supplied in 25, 50, 75 mg tablets. All subjects started at 50mg once daily and dose was increased or decreased based on platelet count (target range 50-200Gi/L). Alternate days and interruption of dosing was permitted to maintain target range of platelet count. Doses could range from 25 to 75mg. Subjects could remain on treatment up to 2 years.
- id
- BG000
- title
- Eltrombopag
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 15.61
- value
- 48.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 201
- title
- Female
- measurements
- group Id
- BG000
- value
- 101
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 101
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 201
- title
- No
- param Type
- NUMBER
- title
- Concomitant ITP Medication at Baseline
- unit Of Measure
- Participant
- classes
- categories
- measurements
- group Id
- BG000
- value
- 115
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 187
- title
- No
- param Type
- NUMBER
- title
- Splenectomy Status at Baseline
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 211
- title
- <30 Gi/L
- categories
- measurements
- group Id
- BG000
- value
- 52
- title
- 30 - 50 Gi/L
- categories
- measurements
- group Id
- BG000
- value
- 39
- title
- > 50 Gi/L
- param Type
- NUMBER
- title
- Baseline Platelet Count
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle